Chronic arsenicism;Arsenicisme chronique

Annales de Dermatologie et de Venereologie

Volumn 128, Issue 4, 2001, Pages 527-530

  Bourgeais, A M ^a   Avenel Audran, M ^a   Bouil, A L E ^b   Bouyx, C ^c   Allain, P ^b   Verret, J L ^a,b  

^a Serv de Dermatol et Venerologie   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c Rue Joseph Cousin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CARCINOGEN; FUNGICIDE;

AGED; ARSENIC POISONING; ARTICLE; ASTHENIA; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG BLOOD LEVEL; FOLLOW UP; HUMAN; HYPERPIGMENTATION; INHALATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SKIN MANIFESTATION; WINE;

AGED; AGROCHEMICALS; ARSENIC; ARSENIC POISONING; ASTHENIA; CHRONIC DISEASE; FOOD CONTAMINATION; FUNGICIDES, INDUSTRIAL; HAIR; HUMANS; HYPERPIGMENTATION; MALE; NAILS; WINE;

EID: 0034996691     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Yeh S. Skin cancer in chronic arsenicism. Hum Pathol 1973;14:469-85.
2. Levantine A. Drug induced changes in pigmentation. Br J Dermatol 1973;89:105-12.
3. Schwartz RA. Premalignant keratinocytic neoplasms. J Am Acad Dermatol 1996;35:223-42.
4. Cöl M., Cöl C., Soran A., Soyli BS., Öztürk S. Arsenic-related Bowen's disease, palmar keratosis, and skin cancer. Environ Health Perspect 1999;107:687-9.
5. Schwartz RA. Arsenic and the skin. Int J Dermatol 1997;36:241-50.
6. Lin TH, Huang YL, Wang MY. Arsenic species in drinking water, hair, fingernails, and urine of patients with blackfoot disease. J Toxicol Environ Health 1998;53:85-93.
7. Hsueh YM, Cheng CS, Wu MM, Yu HS, Kuo TL, Chen CJ. Multiple risk factors associated with arsenic-induced skin cancer : effects of chronic liver disease and malnutritional status. Br J Cancer 1995;71:109-14.
8. Byrd DM, Luann Roegner M., Griffiths JC, Lamm SH, Grumski KS, Wilson R, et al. Carcinogenic risks of inorganic arsenic in perspective. Int Arch Occup Environ Health 1996;68:484-94.
9. Wong ST, Chan HL, Teo SK. The spectrum of cutaneous and internal malignancies in chronic arsenic toxicity. Singapore Med J 1998;39:171-3.
10. Lien HC, Tsai TF, Lee YY, Hsiao CH. Merkel cell carcinoma and chronic arsenicism. J Am Acad Dermatol 1999;41:641-3.
11. Maloney ME. Arsenic in Dermatology. Dermatol Surg 1996;22:301-4.
12. Hsueh YM, Chiou HY, Huang YL, Wu WL, Huang CC, Yang MH, et al. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev 1997;6:589-96.
13. Karagas MR, Steven Morris J, Weiss JE, Spate V, Baskett C, Robert Greenberg E. Toenail samples as an indicator of drinking water arsenic exposure. Cancer Epidemiol Biomarkers Prev 1996;5:849-52.
14. Pazirandeh A., Brati AH, Ghannadi Marageh M. Determination of arsenic in hair using neutron activation. Appl Radiat Isot 1998;49:753-9.
15. Le Bouil A., Notelet S., Cailleux A., Turcant A., Allain P. Dosage de l'arsenic urinaire après séparation de l'arsenobétaïne. Toxicorama 1997; 9:171-6.
16. Soignet SL, Maslak P., Wang ZG, Jhanwar S., Calleja E., Dardashti LJ, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxyde. N Engl J Med 1998;339:1341-8.
17. Wong SS, Tan KC, Goh CL. Cutaneous manifestations of chronic arsenicism : Review of seventeen cases. J. Am Acad Dermatol 1998;38:179-85.